Skip Navigation
Skip to contents




9 results

Potential Role of the Sigma-1 Receptor Chaperone in the Beneficial Effects of Donepezil in Dementia with Lewy Bodies


  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):43-44.
No abstract available.
Prolonged Delirium Secondary to Hypoxic-ischemic Encephalopathy Following Cardiac Arrest

Yogaratnam J, Jacob R, Naik S, Magadi H, Sim K

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):39-42.
Hypoxic-ischemic brain injury encompasses a complex constellation of pathophysiological and cellular brain injury induced by hypoxia, ischemia, cytotoxicity, or combinations of these mechanisms and can result in poor outcomes including...
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review

Tokutsu Y, Umene-Nakano W, Shinkai T, Yoshimura , Okamoto T, Katsuki A, Hori H, Ikenouchi-Sugita A, Hayashi K, Atake K, Nakamura J

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):34-38.
OBJECTIVE: Electroconvulsive therapy (ECT) has proven to be effective in treatment-resistant depression (TRD). In recent reports, 70% to 90% of patients with TRD responded to ECT. However, post-ECT relapse is...
Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study

Li H, Li T, Li Y, Shen Y

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):28-33.
OBJECTIVE: Duloxetine hydrochloride is a selective serotonin (5-hydroxytryptamine) and norepinephrine reuptake inhibitor. It is approved for effective treatment for major depressive disorder. The pharmacokinetics (PK) of duloxetine has been studied,...
A Longitudinal Study of Relation between Side-effects and Clinical Improvement in Schizophrenia: Is There a Neuro-metabolic Threshold for Second Generation Antipsychotics?

Venkatasubramanian G, Rao NP, Arasappa R, Kalmady SV, Gangadhar

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):24-27.
OBJECTIVE: Classical studies demonstrated Neuroleptic Induced Extrapyramidal Side-effects (NIES; Neuroleptic threshold) to correlate with the efficacy of first generation antipsychotics. Second generation antipsychotics (SGAs), in addition to the extrapyramidal side...
Factor Structure of the Targeted Inventory on Problems in Schizophrenia

Tanaka S, Nagase T, Suzuki T, Nomura K, Takeuchi H, Nakajima S, Uchida H, Yagi G, Watanabe K, Mimura M

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):18-23.
OBJECTIVE: The aim of this study was to explore the factor structure of a novel, 10-item rating scale, the Targeted Inventory on Problems in Schizophrenia (TIP-Sz). Determining the factor structure...
No Association between the Response to Methylphenidate and DRD4 Gene Polymorphism in Korean Attention Deficit Hyperactivity Disorder: A Case Control Study

Ji HS, Paik KC, Park WS, Lim MH

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):13-17.
OBJECTIVE: Recently the relationship between alleles frequency distribution, drug response and the attention deficit hyperactivity disorder (ADHD), has been actively researched. We investigated the association between the genetic type, alleles...
Phentermine, Sibutramine and Affective Disorders

An H, Sohn H, Chung S

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):7-12.
A safe and effective way to control weight in patients with affective disorders is needed, and phentermine is a possible candidate. We performed a PubMed search of articles pertaining to...
Long-acting Injectable Antipsychotics in First-episode Schizophrenia

Jeong HG, Lee MS

  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):1-6.
Antipsychotic medications are important for the successful management of schizophrenia. Continuous treatment with medication is superior in relapse prevention and non-adherence to antipsychotic medication is associated with a poor clinical...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: